MetLife, Inc. (NYSE:MET)‘s stock had its “buy” rating reaffirmed by investment analysts at Wells Fargo & Company in a report issued on Monday.

Other equities research analysts have also recently issued research reports about the company. Keefe, Bruyette & Woods restated a “buy” rating and set a $59.00 price objective on shares of MetLife in a report on Thursday. Zacks Investment Research cut MetLife from a “hold” rating to a “sell” rating in a research note on Wednesday, April 26th. TheStreet upgraded MetLife from a “c” rating to a “b-” rating in a research note on Monday, July 24th. FBR & Co upgraded MetLife from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $54.00 to $58.00 in a research note on Thursday, May 25th. Finally, J P Morgan Chase & Co initiated coverage on MetLife in a research note on Monday, July 24th. They set a “hold” rating and a $78.00 target price for the company. Two research analysts have rated the stock with a sell rating, six have issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. MetLife presently has a consensus rating of “Hold” and an average price target of $59.02.

Shares of MetLife (NYSE:MET) traded up 1.46% on Monday, reaching $48.75. The company’s stock had a trading volume of 5,883,384 shares. The stock has a market cap of $53.00 billion, a PE ratio of 547.75 and a beta of 1.46. MetLife has a 1-year low of $38.87 and a 1-year high of $58.09. The company’s 50 day moving average is $54.59 and its 200-day moving average is $53.07.

MetLife (NYSE:MET) last released its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $17.39 billion for the quarter, compared to the consensus estimate of $17.11 billion. MetLife had a return on equity of 8.51% and a net margin of 0.30%. MetLife’s quarterly revenue was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.83 earnings per share. On average, equities analysts predict that MetLife will post $5.31 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/07/metlife-inc-met-stock-rating-reaffirmed-by-wells-fargo-company-2.html.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MET. BlackRock Inc. raised its position in MetLife by 3,323.3% in the first quarter. BlackRock Inc. now owns 68,475,870 shares of the financial services provider’s stock worth $3,616,895,000 after buying an additional 66,475,603 shares in the last quarter. Vanguard Group Inc. raised its position in MetLife by 3.0% in the first quarter. Vanguard Group Inc. now owns 65,364,620 shares of the financial services provider’s stock worth $3,452,559,000 after buying an additional 1,885,246 shares in the last quarter. State Street Corp raised its position in MetLife by 1.4% in the first quarter. State Street Corp now owns 49,020,964 shares of the financial services provider’s stock worth $2,589,297,000 after buying an additional 680,903 shares in the last quarter. Geode Capital Management LLC raised its position in MetLife by 6.9% in the first quarter. Geode Capital Management LLC now owns 10,265,096 shares of the financial services provider’s stock worth $541,427,000 after buying an additional 664,918 shares in the last quarter. Finally, Morgan Stanley raised its position in MetLife by 5.4% in the first quarter. Morgan Stanley now owns 7,946,397 shares of the financial services provider’s stock worth $419,728,000 after buying an additional 404,104 shares in the last quarter. Institutional investors and hedge funds own 74.83% of the company’s stock.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.